1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCancer Detection and Diagnosis Research (R03) is sponsored by National Cancer Institute (NCI). Provides support for small-scale, short-term projects in cancer detection and diagnosis.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NCI Small Grants Program for Cancer Research - Oncology News, Insights, Stories by OncoDaily NCI Small Grants Program for Cancer Research The NCI Small Grants Program (R03) is an NIH funding mechanism that provides modest, short-duration support for pilot projects in cancer research. This omnibus program is ideal for early-stage investigators or established researchers exploring new directions.
An NCI R03 grant can supply up to $50,000 per year for 2 years (maximum $100,000 total) to gather preliminary data or test proof-of-concept ideas in areas relevant to cancer biology, prevention, diagnosis, treatment, or survivorship . Projects should be well-defined and achievable within the limited budget/scope – for example, feasibility studies, secondary analyses, or development of research methodology.
The goal is often to produce data that will lead to a larger grant (R01) or significantly advance a niche of cancer science. Open to investigators at any career stage who are eligible to apply as NIH PI. Early-career researchers are encouraged (the R03 is a common first grant for new investigators), but senior scientists can also use it for exploratory work.
The research scope must fall under the mission of the National Cancer Institute. This includes basic laboratory studies of cancer, translational research, clinical research (excluding large trials), population and epidemiology studies, behavioral research, health services research, etc., as long as it addresses cancer. Applicants can be based in the U.S. or abroad (foreign institutions are allowed with certain restrictions).
There is no U.S. citizenship requirement. Note: An investigator may not concurrently hold another NIH small grant of similar scope. Typically, R03 projects do not involve extensive human subjects or animal work that would exceed the small scale.
Grant amount: Up to $50,000 direct costs per year for 2 years . (NCI allows requests of $50K/year; no more than $100K over the entire project). This budget can cover personnel (often partial salary for the PI or research assistant), supplies, core facility fees, small equipment, and other research expenses.
Indirect costs can be added on top as per institution’s federally negotiated rate (so total award might be slightly higher including indirects). Project period: 2 years maximum. No renewal option for R03 – it is non-renewable.
However, PIs can later seek an R01 or larger grant based on R03 results. Because of the limited scope, clinical trials are not allowed on an R03 (clinical research is okay, but not trials). The work should be completed within 2 years.
Progress reporting follows standard NIH requirements. January 8, 2026 – This is the standard receipt date for NCI (and NIH) small grant applications for the January cycle . (If missed, the next standard deadlines are in spring and fall.)
Applications must be submitted via Grants. gov by 5:00 PM local time on that date. The funding opportunity announcement is PAR-25-078 .
Council review and earliest start date for applications submitted by Jan 8, 2026 will be later in 2026.
Where to go for further information: Global fight against cancer MD Anderson Cancer Center Dana-Farber Cancer Institute American Society of Clinical Oncology European Cancer Organisation National Cancer Institute Memorial Sloan Kettering Cancer Center European School of Oncology The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Small businesses in the U. S. Confirm the full requirements in the official notice before applying.
Cancer Detection and Diagnosis Research (R03) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article